Project Grant R25CA298917
- The National Cancer Institute awarded a $307,680 Project Grant to the University of Wisconsin-Madison (UW) under the Cancer Research Manpower (CFDA 93.398) program. The grant, titled "ASSURE ADVANCED RADIOLOGICAL SCIENCES PROGRAM," aims to establish an immersive summer research experience in radiological sciences for 17 undergraduate students. The program will provide cancer-focused scientific training, including didactic lectures, mentored research experiences, and interactive...
- The National Cancer Institute (NCI) awarded a $159,450 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to Wayne State University to support the "NextGen Oncology Scholars: Nurturing Tomorrow's Pioneers" program. This 5-year grant, beginning August 15, 2025 and ending July 31, 2030, aims to cultivate the next generation of cancer researchers by providing undergraduate students with hands-on research experiences, didactic training, clinical exposure, and structured...
- The National Cancer Institute (NCI) awarded a $223,823 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the University of Kentucky Research Foundation. The Markey STRONG Scholars Program aims to address high cancer rates in Kentucky by enhancing the training and development of the next generation of cancer researchers and medical care practitioners. The program will provide undergraduate STEM students with transdisciplinary mentored research experiences, cancer...
- The University of Cincinnati's Sponsored Research Services Division was awarded a $383,491 Project Grant from the National Cancer Institute under the Cancer Research Manpower (CFDA 93.398) federal grant program. The grant, awarded on July 1, 2025 with a completion date of June 30, 2030, will fund a Training Program in Basic and Translational Oncology. The program aims to increase the number of researchers with a strong background in cancer biology who can effectively translate scientific...
- The federal Project Grant award of $369,564.00 was provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program. The award supports the "STUDENTS AND TEACHERS ACHIEVING CANCER RESEARCH EXPERIENCES TOGETHER (START) PROGRAM" aimed at expanding representation of underserved secondary school students in science careers through cancer research and education initiatives in the community surrounding the University of Colorado Anschutz Medical Campus...
- The National Cancer Institute awarded a $197,747 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the University of North Carolina at Chapel Hill. The grant, titled "IMPROVING AFFORDABILITY IN CANCER CARE THROUGH ECONOMIC SCREENING AND SUPPORT (I-ACCESS)", aims to pilot and refine a screening assessment and referral program to proactively identify cancer-related financial hardship in patients and connect them with financial education, counseling, and resources....
- The National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, awarded a $677,998 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to The Medical College of Wisconsin, Inc. (MCW). The project aims to externally validate and integrate radiopathomic models developed using autopsy and biopsy samples to better delineate the true extent of glioma tumors and identify microscopic infiltrating tumor cells. The research will refine...
- The National Cancer Institute (NCI) awarded a $1,034,176 Project Grant to the Sloan-Kettering Institute for Cancer Research under the Cancer Biology Research program (CFDA 93.396) with an award date of August 18, 2025. The grant aims to understand the mechanisms of aberrant RNA splicing and how it drives the development of various hematological malignancies, including myelodysplastic syndrome, chronic lymphocytic leukemia, and acute myeloid leukemia. The research builds on the institution's past...
- The National Cancer Institute (NCI) awarded a $170,641 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the Dana-Farber Cancer Institute, Inc. (DFCI) in Boston, Massachusetts. The purpose of this 2-year award, which runs from August 1, 2025 to July 31, 2027, is to advance the understanding of tumor-immune spatial interactions in mismatch-repair stratified colorectal cancers. The research aims to identify immunologically distinct subsets of mismatch-repair proficient...
- The U.S. National Cancer Institute (NCI) awarded a $122,032 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to Weill Medical College of Cornell University. The grant, with a period of performance from February 1, 2025 to January 31, 2027, will fund research to study the role of aberrant mRNA splicing in cancer cell heterogeneity and its potential as a target for immunotherapeutic strategies. The research aims to utilize advanced computational and single-cell approaches...
The National Cancer Institute awarded a $324,000 Project Grant to The Medical College of Wisconsin, Inc. under the Cancer Research Manpower (CFDA 93.398) program. The goal of this 5-year grant, awarded on August 7, 2025, is to collaborate with community partners to identify and educate a group of undergraduate students (SPARCC Scholars) from surrounding Milwaukee-area institutions who wish to develop careers in biomedical, behavioral, and clinical cancer research. The program will provide SPARCC Scholars with financial stipends, individualized mentorship, and access to a professional network to reduce barriers to participation and ensure a psychologically safe learning environment. The students will participate in a 12-week program that includes cancer-focused mentored research, educational workshops, and practicum rotations to gain knowledge and training in techniques required to bridge basic, preclinical, and community research to patient care, including the role of clinical trials.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $324.0k | 8/6/25 |